These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2033720

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer.
    Chin JL, Kadhim SA, Batislam E, Karlik SJ, Garcia BM, Nickel JC, Morales A.
    J Urol; 1996 Sep; 156(3):1189-93. PubMed ID: 8709344
    [Abstract] [Full Text] [Related]

  • 4. Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging.
    Kikuchi E, Xu S, Ohori M, Matei C, Lupu M, Menendez S, Koutcher JA, Bochner BH.
    J Urol; 2003 Oct; 170(4 Pt 1):1375-8. PubMed ID: 14501772
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87).
    Chong L, Ruping Y, Jiancheng B, Guohong Y, Yougang F, Jiansong W, Xiang G, Jie H, Shusheng X.
    Cancer Biol Ther; 2006 Apr; 5(4):394-8. PubMed ID: 16481738
    [Abstract] [Full Text] [Related]

  • 6. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C, Yan RP, Yuan GH, Feng YG, Wang JS, Gao X, Huang YS, Zhou JB, Xie SS.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [Abstract] [Full Text] [Related]

  • 7. [Establishment and application of an orthotopic murine bladder cancer model].
    Yang SM, Wen DG, Hou JQ, He J, Cen JN, Chen JH.
    Ai Zheng; 2007 Apr; 26(4):341-5. PubMed ID: 17430648
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.
    Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, Moore RB.
    Br J Cancer; 1999 Oct; 81(4):638-46. PubMed ID: 10574249
    [Abstract] [Full Text] [Related]

  • 9. Anti-tumor effect of tumor necrosis factor and its induction of tumor variant of MBT-2 transitional cell carcinoma of the bladder.
    Kadhim SA, Chin JL.
    J Urol; 1988 May; 139(5):1091-4. PubMed ID: 3361654
    [Abstract] [Full Text] [Related]

  • 10. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
    Horiguchi Y, Larchian WA, Kaplinsky R, Fair WR, Heston WD.
    Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) in a mouse bladder tumor (MBT-2).
    Bahnson RR, Ratliff TL.
    J Urol; 1990 Jul; 144(1):172-5. PubMed ID: 2113589
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
    Tamura K, Kikuchi E, Konno T, Ishihara K, Matsumoto K, Miyajima A, Oya M.
    BMC Cancer; 2015 Apr 26; 15():317. PubMed ID: 25928041
    [Abstract] [Full Text] [Related]

  • 13. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E.
    J Urol; 1997 Aug 26; 158(2):646-52. PubMed ID: 9224385
    [Abstract] [Full Text] [Related]

  • 14. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
    Venz S, Ilg J, Ebert T, Hierholzer J, Friedrichs R, Hosten N, Felix R.
    Urologe A; 1996 Jul 26; 35(4):297-304. PubMed ID: 8928358
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2.
    Takahashi T, Kushiro A, Nomoto K, Uchida K, Morotomi M, Yokokura T, Akaza H.
    J Urol; 2001 Dec 26; 166(6):2506-11. PubMed ID: 11696819
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A.
    Anticancer Res; 2009 Jun 26; 29(6):2067-76. PubMed ID: 19528466
    [Abstract] [Full Text] [Related]

  • 17. Concomitant treatment of MBT-2 bladder tumour by tumour necrosis factor alpha and interferon alpha in conjunction with delayed type hypersensitivity immunotherapy.
    Kadhim SA, Chin JL.
    Urol Res; 1991 Jun 26; 19(1):57-62. PubMed ID: 1674182
    [Abstract] [Full Text] [Related]

  • 18. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model.
    Chade DC, Andrade PM, Borra RC, Leite KR, Andrade E, Villanova FE, Srougi M.
    Int Braz J Urol; 2008 Jun 26; 34(2):220-6; discussion 226-9. PubMed ID: 18462521
    [Abstract] [Full Text] [Related]

  • 19. [Immobilization of streptavidin-tagged bioactive hTNF-alpha on biotinylated mucosal surface of the bladder wall for treatment of superficial bladder cancer in mice].
    Chen Z, Tan WL, Huang X, Liang ZK, Xu CX, Gao JM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 26; 30(5):936-40. PubMed ID: 20501361
    [Abstract] [Full Text] [Related]

  • 20. Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
    Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E.
    J Exp Med; 1993 Apr 01; 177(4):1127-34. PubMed ID: 8459207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.